Eli Lilly's valuation looks far more attractive now than it did even a year ago.

Eli Lilly is coming off an impressive first-quarter performance, with sales soaring by 56%.

Eli Lilly (LLY) stock is pulling back ahead of its first-quarter earnings report, due out before the open on Thursday, April ...

Eli Lilly has another promising drug in its portfolio with Foundayo. Its growth rate has been more than 40% in recent quarters due to the success of its current GLP-1 drugs. The stock's valuation is ...

The trillion-dollar club is an exclusive one, featuring some of the most successful and promising companies in the world. Joining the ranks and reaching a $1 trillion valuation is a milestone. But ...